Primary pulmonary hypertension, hyperuricaemia and renal function

M. M. Hoeper, S. Ehlerding, M. Schwarze, E. Spiekerkoetter, H. Fabel (Hannover, Germany)

Source: Annual Congress 2001 - Pulmonary hypertension (miscellanea)
Session: Pulmonary hypertension (miscellanea)
Session type: Thematic Poster Session
Number: 2808
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. M. Hoeper, S. Ehlerding, M. Schwarze, E. Spiekerkoetter, H. Fabel (Hannover, Germany). Primary pulmonary hypertension, hyperuricaemia and renal function. Eur Respir J 2001; 16: Suppl. 31, 2808

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Amfepramone does not cause primary pulmonary hypertension
Source: Eur Respir J 2004; 23: 790
Year: 2004


Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
Source: Eur Respir J 2007; 30: 715-721
Year: 2007



Primary pulmonary hypertension and endothelial dysfunction
Source: Eur Respir J 2003; 22: Suppl. 45, 583s
Year: 2003

Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


Fluid-challenge testing to distinguish PAH from pulmonary hypertension secondary to heart failure
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

When is pulmonary hypertension not pulmonary hypertension?
Source: Eur Respir J 2001; 18: Suppl. 33, 522s
Year: 2001

Portopulmonary hypertension
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129
Year: 2005

Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
Source: Eur Respir J 2009; 34: 770
Year: 2009


Pulmonary hypertension is common in end-stage sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007

Pulmonary hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir Mon 2012; 57: 148-160
Year: 2012


Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Source: Eur Respir J 2001; 17: 1065-1069
Year: 2001


Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Pulmonary arterial hypertension in end-stage idiopathic pulmonary fibrosis: a hypothetic role for viral infections
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


Pulmonary hypertension: pathophysiology and diagnosis
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007



ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021


Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007



Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 472
Year: 2011